Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taskar, V. S.
Right arrow Articles by Coultas, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taskar, V. S.
Right arrow Articles by Coultas, D. B.
The Proceedings of the American Thoracic Society 3:293-298 (2006)
© 2006 The American Thoracic Society

Is Idiopathic Pulmonary Fibrosis an Environmental Disease?

Varsha S. Taskar and David B. Coultas

Department of Medicine, The University of Texas Health Center at Tyler, Tyler, Texas

Correspondence and requests for reprints should be addressed to David Coultas, M.D., The University of Texas Health Center at Tyler, 11937 U.S. Highway 271, Tyler, TX 75708. E-mail: david.coultas{at}uthct.edu

ABSTRACT

Several sources of evidence, including investigations of pathogenesis and observational studies, support the hypothesis that environmental agents may have an etiologic role in idiopathic pulmonary fibrosis (IPF). Since 1990, six case-control studies have been conducted in three countries and have consistently demonstrated increased risk of IPF with exposures to a number of environmental and occupational agents. In a meta-analysis of these studies, six exposures were significantly associated with IPF (summary odds ratios [95% confidence intervals]), including ever smoking (1.58 [1.27–1.97]), agriculture/farming (1.65 [1.20–2.26]), livestock (2.17 [1.28–3.68]), wood dust (1.94 [1.34–2.81]), metal dust (2.44 [1.74–3.40]), and stone/sand (1.97 [1.09–3.55]). Although there are a number of limitations of the case-control design and these results alone do not establish a causal link, an assessment of all of the available evidence strongly suggests that IPF may be a heterogeneous disorder caused by a number of environmental and occupational exposures.

Key Words: interstitial lung diseases • occupation • risk • smoking




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Behr and V. J. Thannickal
Update in Diffuse Parenchymal Lung Disease 2008
Am. J. Respir. Crit. Care Med., March 15, 2009; 179(6): 439 - 444.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A. W. Fogarty
The Association between Idiopathic Pulmonary Fibrosis and Vascular Disease: A Population-based Study
Am. J. Respir. Crit. Care Med., December 15, 2008; 178(12): 1257 - 1261.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
A. K. Attili, E. A. Kazerooni, B. H. Gross, K. R. Flaherty, J. L. Myers, and F. J. Martinez
Smoking-related Interstitial Lung Disease: Radiologic-Clinical-Pathologic Correlation
RadioGraphics, September 1, 2008; 28(5): 1383 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells
Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 190 - 194.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Pottier, C. Chupin, V. Defamie, B. Cardinaud, R. Sutherland, G. Rios, F. Gauthier, P. J. Wolters, Y. Berthiaume, P. Barbry, et al.
Relationships between Early Inflammatory Response to Bleomycin and Sensitivity to Lung Fibrosis: A Role for Dipeptidyl-Peptidase I and Tissue Inhibitor of Metalloproteinase-3?
Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1098 - 1107.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
E. Fireman, Y Lerman, M Ben Mahor, E Ganor, and M. Kramer
Redefining idiopathic interstitial lung disease into occupational lung diseases by analysis of chemical composition of inhaled dust particles in induced sputum and/or lung biopsy specimens
Toxicology and Industrial Health, November 1, 2007; 23(10): 607 - 615.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. L. Olson, J. J. Swigris, D. C. Lezotte, J. M. Norris, C. G. Wilson, and K. K. Brown
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 277 - 284.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Arakawa, T. Johkoh, K. Honma, Y. Saito, Y. Fukushima, H. Shida, and N. Suganuma
Chronic Interstitial Pneumonia in Silicosis and Mix-Dust Pneumoconiosis: Its Prevalence and Comparison of CT Findings With Idiopathic Pulmonary Fibrosis
Chest, June 1, 2007; 131(6): 1870 - 1876.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
C. Mueller-Mang, C. Grosse, K. Schmid, L. Stiebellehner, and A. A. Bankier
What Every Radiologist Should Know about Idiopathic Interstitial Pneumonias
RadioGraphics, May 1, 2007; 27(3): 595 - 615.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.
 
CCM abstracts